Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2005 | 07-2004 | 07-2003 | 07-2002 | 07-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 14 | 49 | 4 | 41 |
| Marketable Securities | N/A | N/A | 32 | 651 | 2,148 |
| Receivables | 614 | 208 | 199 | 361 | 155 |
| Inventories | 2 | 11 | 110 | N/A | N/A |
| TOTAL | $626 | $251 | $414 | $1,019 | $2,371 |
| Non-Current Assets | |||||
| PPE Net | 104 | 79 | 52 | 343 | 2,297 |
| Intangibles | 254 | 216 | 698 | 1 | 4 |
| TOTAL | $359 | $294 | $749 | $344 | $2,301 |
| Total Assets | $985 | $546 | $1,164 | $1,363 | $4,672 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 42 | 110 | 66 | N/A | N/A |
| Accounts payable and accrued liabilities | 899 | 448 | 255 | 74 | 493 |
| Other current liabilities | 530 | 26 | 36 | N/A | N/A |
| TOTAL | $1,554 | $755 | $469 | $74 | $493 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 82 | 172 | 112 | N/A | N/A |
| Other Non-Current Liabilities | 94 | 0 | 453 | 0 | 0 |
| TOTAL | $101 | $26 | $453 | $N/A | $N/A |
| Total Liabilities | $1,655 | $781 | $922 | $74 | $493 |
| Shareholders' Equity | |||||
| Retained earnings | -19,728 | -15,606 | -13,346 | -10,742 | -8,313 |
| Other shareholders' equity | 2,341 | 1,696 | 1,551 | 1,375 | 636 |
| TOTAL | $-671 | $-236 | $242 | $1,289 | $4,179 |
| Total Liabilities And Equity | $985 | $546 | $1,164 | $1,363 | $4,672 |